Paradigm Biopharmaceuticals (ASX: PAR) has taken a major step forward in its mission to develop new treatments for osteoarthritis, securing centralised Human Research Ethics Committee (HREC) approval for its pivotal…
NEXTDC Delivers Record 1H25 Results Amid Strong Growth and Expansion
NEXTDC Limited (ASX: NXT) has posted record results for the first half of FY25, with net revenue climbing 13% to $167.8 million and underlying EBITDA rising 3% to $105.4 million….
Nuix Reports Solid 1H25 Results Amid Strategic Growth Initiatives
Nuix (ASX: NXL) has reported steady growth for the first half of FY25, with Annualised Contract Value (ACV) increasing by 8.3% to $216.2 million and statutory revenue rising 6.9% to…
Lovisa Continues Growth Momentum with Strong 1H FY25 Results
Lovisa (ASX: LOV) has delivered another strong financial performance in the first half of FY25, continuing its growth trajectory despite economic headwinds. Revenue rose 8.8% year-over-year to $405.9 million, largely…
Telix Delivers Record 2024 Results, Sets Sights on Billion-Dollar Revenue in 2025
Melbourne, Australia & Indianapolis, USA – 20 February 2025 – Telix Pharmaceuticals (ASX: TLX, Nasdaq: TLX) has wrapped up a record-breaking year, delivering strong financial growth while laying the foundation…
Guzman y Gomez Serves Up Strong Growth in 1H25, Set to Outperform FY25 Forecasts
Sydney, 21 February 2025 – Guzman y Gomez (ASX: GYG) has dished up a sizzling first-half performance, with strong sales and earnings putting the company on track to beat its…
Domain (ASX: DHG) Receives $4.20 Per Share Takeover Proposal from CoStar
Sydney, 21 February 2025 – Domain Holdings Australia Limited (ASX: DHG) has received an unsolicited, non-binding indicative takeover proposal from US-based CoStar Group, Inc. (NASDAQ: CSGO) to acquire 100% of…
Codan (ASX: CDA) Posts Strong H1 FY25 Results as Communications Business Leads the Charge
Codan Limited (ASX: CDA) has delivered another standout half-year performance, with revenue jumping 15% to $305.6 million, driven by the continued strength of its Communications business. EBIT and NPAT both…
Accent Group (ASX: AX1) Delivers Solid H1 FY25 Results Amid Challenging Retail Conditions
Accent Group (ASX: AX1) has posted a strong first-half performance, reporting sales growth, higher profits, and continued expansion despite a tough retail environment. The Group delivered an 11.5% increase in…
Alcidion (ASX: ALC) Lands Major 10-Year EPR Contract with UK’s North Cumbria Integrated Care
Alcidion (ASX: ALC) has secured a significant 10-year contract worth ~$37.5M (£19.0M) with North Cumbria Integrated Care NHS Foundation Trust (NCIC) for the implementation of its Miya Precision Electronic Patient…